[Successful treatment of chronic myelomonocytic leukemia (CMMoL) with N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PLAC)].
Ozawa
M
M
Iwamoto
K
K
Kitani
K
K
Mizuno
T
T
Kobayashi
Y
Y
Horiuchi
H
H
Maruo
N
N
Kondo
M
M
Horiike
S
S
Misawa
S
S
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D007446:Chromosome Inversion; D002878:Chromosomes, Human, Pair 1; D003561:Cytarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000473:pathology; D006801:Humans; D007621:Karyotyping; D015477:Leukemia, Myelomonocytic, Chronic / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D012074:Remission Induction
D000970:Antineoplastic Agents; D003561:Cytarabine; C047643:N(4)-palmitoyl cytarabine